Treatment of primary hyperaldosteronism

Area of Science:

• Endocrinology and Hypertension
• Cardiovascular Medicine
• Nephrology

Background:

• Primary aldosteronism presents higher cardiovascular and renal risks than essential hypertension, even with similar blood pressure levels.
• Aldosterone excess necessitates specific treatments to mitigate adverse cardiovascular and renal outcomes.

Purpose of the Study:

• To review and compare medical and surgical treatment options for primary aldosteronism.
• To identify circumstances where medical management is preferable to adrenalectomy.
• To discuss special patient populations for whom medical therapy is indicated first-line.

Main Methods:

• Review of existing literature comparing medical and surgical treatments for primary aldosteronism.
• Analysis of adrenal vein sampling limitations and risks.
• Evaluation of adrenalectomy risks and efficacy versus medical treatment safety and efficacy.

Main Results:

• Adrenal vein sampling has limited experience, efficacy, and potential risks.
• Adrenalectomy carries risks and demonstrates lower efficacy compared to medical treatment.
• Medical treatment for primary aldosteronism shows high safety and efficacy.

Conclusions:

• Medical treatment is a safe and effective option for primary aldosteronism.
• Medical therapy is particularly indicated as first-line treatment in pregnancy, elderly patients, and hereditary forms.
• Treatment decisions should consider individual patient circumstances and the comparative risks and benefits of medical versus surgical approaches.